Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens (Q33179158)

23 July 2017

Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens (English)

1 reference

23 July 2017

A Denis

1

1 reference

23 July 2017

C Agouridas

2

1 reference

23 July 2017

J M Auger

3

1 reference

23 July 2017

Y Benedetti

4

1 reference

23 July 2017

A Bonnefoy

5

1 reference

23 July 2017

F Bretin

6

1 reference

23 July 2017

J F Chantot

7

1 reference

23 July 2017

A Dussarat

8

1 reference

23 July 2017

C Fromentin

9

1 reference

23 July 2017

S G D'Ambrières

10

1 reference

23 July 2017

S Lachaud

11

1 reference

23 July 2017

P Laurin

12

1 reference

23 July 2017

O Le Martret

13

1 reference

23 July 2017

V Loyau

14

1 reference

23 July 2017

N Tessot

15

1 reference

23 July 2017

J M Pejac

16

1 reference

23 July 2017

S Perron

17

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

23 July 2017

6

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

23 July 2017

9

1 reference

23 July 2017

3075-3080

1 reference

23 July 2017

21

1 reference

Pneumococcal macrolide resistance--myth or reality?

23 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900534-X

7 January 2021

Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900534-X

7 January 2021

Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900534-X

7 January 2021

Comparative in-vitro activity of cefoperazone/sulbactam and 11 other agents against multidrug resistant Bacteroides fragilis group species

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900534-X

7 January 2021

Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900534-X

7 January 2021

Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900534-X

7 January 2021

3-Keto-11,12-carbazate derivatives of 6-O-methylerythromycin A synthesis and in vitro activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900534-X

7 January 2021

Synthesis and antiinflammatory activity of some 1,2,3- and 1,2,4-triazolepropionic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900534-X

7 January 2021

Ketolides lack inducibility properties of MLS(B) resistance phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900534-X

7 January 2021

Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900534-X

7 January 2021

In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900534-X

7 January 2021

10.1016/S0960-894X(99)00534-X

Identifiers

DOI

1 reference

23 July 2017

1 reference